APONTIS PHARMA AG / Key word(s) ...EUR 20.8 million), APONTIS PHARMA continues to have a solid asset and financial position to finance the further growth planned and the expansion of the product portfolio ... About APONTIS PHARMA..
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and regulatory approval in the Rett Syndrome market.
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and regulatory approval in the Retinitis Pigmentosa market.
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and regulatory approval in the Metastatic Melanoma market.
Nifty Financial Services rose over 1% higher, Nifty Bank was up 0.5% while Nifty Auto, Media, Metal, Pharma, and Realty opened with gains. Bajaj Finance soars ... Bajaj Finance share price soars 7% following RBI ban reversal.
SCHOTT Pharma AG & Co ... SCHOTT Pharma appoints Tobias Erfurth as Head of Investor Relations ... “Tobias joining our finance team is a real win for SCHOTT Pharma ... Almuth Steinkühler, CFO of SCHOTT Pharma ... About SCHOTT Pharma ... SCHOTT Pharma AG & Co.
ChrysCap, Kedaara prepare their biggest funds everFounded in 1999, ChrysCapital has raised over $5 billion across nine funds and backed marquee companies including Infosys Ltd, Hexaware Technologies...
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and ...
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and ...
It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and ...